Top Pharmaceutical Companies Continue Massive M&A – Here's Your Profit Play

Two of the world's top pharmaceutical companies have announced a merger today (Thursday), and that's another major buy signal for one of our favorite profit opportunities. AbbVie Inc. (NYSE: ABBV ) officials announced they will purchase Pharmacyclics Inc. (Nasdaq: PCYC ) for roughly $21 billion. The deal gives Abbvie access to one of the world's top-selling cancer drugs, Imbruvica. Revenue from Imbruvica alone is expected to hit $1 billion in 2015 and $5.8 billion by 2020. The post Top Pharmaceutical Companies Continue Massive M&A – Here's Your Profit Play appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.